Parexel International Corp:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Parexel International Corp - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C11427
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corp – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Parexel International Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Parexel International Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Parexel International Corp, Medical Equipment, Deal Details 11
Private Equity 11
Pamplona Capital Management Acquires Parexel International for USD5 Billion 11
Debt Offering 13
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 13
Acquisition 14
Parexel International Acquires Quantum Solutions, Contract Research Organization 14
Parexel International Corp – Key Competitors 15
Parexel International Corp – Key Employees 16
Parexel International Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 22
Strategy And Business Planning 22
Oct 24, 2017: PAREXEL and Microsoft Form Cloud Technology Alliance Aimed at Accelerating the Pace of Drug Development 22
Financial Announcements 23
Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 23
May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 24
Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 26
Corporate Communications 28
Nov 12, 2018: Parexel announces appointment of new members to its Board of Directors 28
Aug 16, 2018: PAREXEL announces appointment of two key executives 30
Apr 25, 2018: PAREXEL Names Peyton Howell as Chief Commercial and Strategy Officer 31
Mar 05, 2018: PAREXEL Names Jamie Macdonald As Chief Executive Officer 32
Feb 26, 2018: PAREXEL Receives Two Industry Recognitions for its Diverse and Flexible Workplace 33
Nov 15, 2017: PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry 34
Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 35
Product News 36
Oct 09, 2018: PAREXEL announces several new patient-centric innovations to address drug development challenges 36
Dec 12, 2017: PAREXEL Launches Perceptive Cloud for the Life Sciences Industry 37
Other Significant Developments 38
Oct 31, 2018: PAREXEL navigates China’s complex drug development and market landscape for global biopharmaceutical companies with new China Advisory Service 38
Dec 18, 2017: PAREXEL Announces Enhanced Global Data Operations Offering to Drive Efficiencies for Life Science Companies 39
Oct 26, 2017: PAREXEL Enhances Its Active Tracking Service with Bluetooth Capability to Improve Monitoring of Temperature-Controlled Medication 40
Mar 30, 2017: PAREXEL Launches Patient Sensor Solution to Transform Clinical Trial Data Collection 41
Feb 13, 2017: PAREXEL Launches ClinPhone RTSM Mobile App to Improve Supply Management and Increase Patient Safety 42
Jan 26, 2017: PAREXEL Expands Managed Access Programs Service Offering 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Parexel International Corp, Medical Equipment, Key Facts 2
Parexel International Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Parexel International Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Parexel International Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Deals By Market, 2012 to YTD 2018 9
Parexel International Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Pamplona Capital Management Acquires Parexel International for USD5 Billion 11
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 13
Parexel International Acquires Quantum Solutions, Contract Research Organization 14
Parexel International Corp, Key Competitors 15
Parexel International Corp, Key Employees 16
Parexel International Corp, Other Locations 17
Parexel International Corp, Subsidiaries 18

List of Figures
Parexel International Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Parexel International Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Parexel International Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Parexel International Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Parexel International Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Parexel International Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Parexel International Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Parexel International Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Parexel International Corp:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alfresa Holdings Corp (2784):企業の財務・戦略的SWOT分析
    Summary Alfresa Holdings Corp (Alfresa) is a wholesale distributor and manufacturer of pharmaceuticals products. The company is engaged in ethical pharmaceuticals wholesaling business which delivers a wide range of products, including diagnostic reagents and medical devices. It delivers self medicat …
  • Odakyu Electric Railway Co., Ltd. (9007):企業の財務・戦略的SWOT分析
    Odakyu Electric Railway Co., Ltd. (9007) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Liechtensteinische Landesbank Private Clients:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank Private Clients - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Broncus Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Broncus Medical Inc (Broncus), formerly Broncus Technologies Inc is a medical device company that develops navigation, diagnostic and therapeutic technologies for the treatment of patients with lung disease. The company offers Archimedes system, a total lung access platform used for virtual …
  • Vision RT Ltd:企業の戦略的SWOT分析
    Vision RT Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • American Financial Group, Inc.:企業の戦略・SWOT・財務情報
    American Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • AmerisourceBergen Corporation:企業の戦略・SWOT・財務情報
    AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report Summary AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Hemostemix Inc (HEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Hemostemix Inc (Hemostemix), formerly Theravitae Inc, is a biotechnology company that develops, manufactures and commercializes proprietary autologous cell therapy for the treatment of ischemic diseases. The company’s clinical-stage candidate includes ACP-01, an autologous cell therapy for t …
  • Nobilis Health Corp (NHC):企業の財務・戦略的SWOT分析
    Summary Nobilis Health Corp (Nobilis Health), formerly Northstar Healthcare Inc is a healthcare development and management company that offers outpatient surgery and healthcare solutions. The center’s services include surgical services, surgery and critical patient education services. Its surgical s …
  • Sumitomo Dainippon Pharma Co Ltd (4506):製薬・医療:M&Aディール及び事業提携情報
    Summary Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co., Ltd, develops manufacturers, purchases, sells, imports and exports pharmaceutical products. The company focuses on major therapeutic areas which include central nervous system (CNS), cardiovascular, …
  • Gentag Inc-医療機器分野:企業M&A・提携分析
    Summary Gentag Inc (Gentag) is a medical device company that patent and develops wireless sensor technology products. The company provides wireless products to personal health and diagnostics. It offers wireless sensor network services. Gentag’s products comprise medication and packaging sensor, imm …
  • TPI Triunfo Participacoes e Invest. SA (TPIS3):企業の財務・戦略的SWOT分析
    TPI Triunfo Participacoes e Invest. SA (TPIS3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • IntriCon Corp (IIN)-医療機器分野:企業M&A・提携分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products include glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support products …
  • CooperVision Inc-医療機器分野:企業M&A・提携分析
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Memphasys Ltd (MEM):製品パイプライン分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a bio-separations company that develops and commercializes separation techniques based on its membrane technology. The company develops felix, a non-DNA damaging lab instrument for sperm separation that separates sperm from semen samp …
  • Pepco Holdings LLC-エネルギー分野:企業M&A・提携分析
    Summary Pepco Holdings, LLC (Pepco Holdings), formerly Pepco Holdings, Inc., a subsidiary of Exelon Corporation, is a utility services holding company that transmits, distributes and supplies electricity through its subsidiaries. It also distributes and supplies natural gas. The company, through its …
  • Graphic Packaging Holding Company
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Humana Inc.:企業の戦略・SWOT・財務情報
    Humana Inc. - Strategy, SWOT and Corporate Finance Report Summary Humana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務情報
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hovid Berhad (HOVID):企業の財務・戦略的SWOT分析
    Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆